vimarsana.com
Home
Live Updates
BrainStorm Granted Patents for Allogeneic Exosome Platform-Product in Neurological Disorder Treatments : vimarsana.com
BrainStorm Granted Patents for Allogeneic Exosome Platform-Product in Neurological Disorder Treatments
NEW YORK, Dec. 26, 2023 /PRNewswire/ -- Brainstorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today provided an update on the grant...
Related Keywords
Israel ,
Canada ,
Japan ,
Brazil ,
Australia ,
California ,
United States ,
Australian ,
John Mullaly ,
Chaim Lebovits ,
Prnewswire Brainstorm Cell Therapeutics Inc ,
Israel Patent Office ,
European Medicines Agency ,
California Institute For Regenerative Medicine ,
Nasdaq ,
Brainstorm Cell Therapeutics Inc ,
Drug Administration ,
Lifesci Advisors ,
National Ms Society ,
Cell Therapeutics ,
European Patent ,
Cell Type Specific Exosomes ,
Use Thereof ,
Floor Effect ,
Storm Cell Therapeutics ,
Orphan Drug ,
California Institute ,
Regenerative Medicine ,
Special Protocol Assessment ,
Sci Advisors ,
Markets ,
vimarsana.com © 2020. All Rights Reserved.